Formoterol Fumarate and Budesonide Powder for Inhalation is a prescription maintenance medicine formulated for the long-term control of asthma and chronic obstructive pulmonary disease (COPD). This combination brings together two clinically complementary ingredients: Formoterol Fumarate, a long-acting beta-agonist (LABA) that helps relax airway muscles and improve airflow, and Budesonide, an inhaled corticosteroid that helps reduce inflammation and swelling in the lungs. This powder for inhalation is designed for regular daily use to help manage chronic respiratory symptoms such as wheezing, breathlessness, chest tightness, and airflow limitation. It is not intended for immediate relief of sudden breathing attacks or acute exacerbations. The dual-action formulation supports better breathing control by addressing both bronchoconstriction and underlying airway inflammation. The product is suitable for healthcare and pharmaceutical supply requirements where reliable respiratory maintenance therapy is needed. It may be dispensed in bottle form for inhalation use, depending on the presentation and device compatibility. Proper inhalation technique is essential for effective delivery, and users are typically advised to rinse the mouth with water and spit after each dose to reduce the risk of oral thrush and throat irritation. For B2B buyers, this product is relevant for hospitals, pharmacies, respiratory clinics, and medical distributors looking for inhalation therapy products with established use in chronic airway management. Its search-relevant features include formoterol budesonide inhaler powder, LABA corticosteroid combination, maintenance inhalation therapy, asthma control medication, and COPD maintenance treatment.

*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.